NorthWest Biotherapeutics Inc (NWBO)

[CogDiss 1188X]

FDA is only one of 4 regulators and Dr Ashkan holds HUGE sway in the UK. Derisked.

Well DocLogic, I guess my imagination runs more to the negative than yours. After all, I had an Eeyore stuffed animal on my desk for many years.

I just checked GlaxoSmithKline’s immuno-oncology pipeline and they are very committed to the approach, and would obviously view DCVax as a competitor in the long run if/when approved. My guess is that GSK may have more sway with the British regulators than Ashkan, given the resolving door issue. Whether they would use that influence is, in this case, unknown, but the possibility is not zero in my mind.

That said, NWBO is currently my largest position.